CIK 0001710072
- Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821725586
- Phone
- +1 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- 4 Open-market sale General Counsel sold 1,897 shares at $8.90 ($16,893)
- 4 Open-market sale Chief Financial Officer sold 1,336 shares at $8.90 ($11,897)
- 4 Open-market sale Chief Scientific Officer sold 1,602 shares at $8.90 ($14,266)
- 4 Open-market sale CMO sold 3,254 shares at $8.90 ($28,977)
- 4 Open-market sale President and CEO sold 3,203 shares at $8.90 ($28,522)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale General Counsel sold 4,730 shares at $9.76 ($46,155)
- 4 Open-market buy Director bought 484,496 shares at $10.32 ($4,999,999)
- 4 Open-market buy Director bought 484,496 shares at $10.32 ($4,999,999)
- 4 Open-market buy 10% owner bought 484,496 shares at $10.32 ($4,999,999)
- 4 Open-market sale General Counsel sold 4,730 shares at an average $10.91 ($51,598)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 7 of 11 · 203 filings